Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has
emerged as an important complication of COVID-19. A systematic review was done to …

Haemostasis stops bleeding at the site of vascular injury and maintains the integrity of blood
vessels through clot formation. This regulated physiological process consists of complex …

Abstract SARS-CoV-2 vaccine ChAdOx1 nCoV-19 (AstraZeneca) causes a thromboembolic
complication termed vaccine-induced immune thrombotic thrombocytopenia (VITT). Using …

Updated Recommendations from the Advisory Committee on Immunization Practices for Use
of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with …

Antiplatelet agents and anticoagulants are a mainstay for the prevention and treatment of
thrombosis. However, despite advances in antithrombotic therapy, a fundamental challenge …

Recent reports have highlighted rare, and sometimes fatal, cases of cerebral venous sinus
thrombosis (CVST) and thrombocytopenia following the Vaxzevria vaccine. An underlying …

Heparin-induced thrombocytopenia/thrombosis (HIT) is a serious immune reaction to
heparins, characterized by thrombocytopenia and often severe thrombosis with high …

Coronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has impacted nearly every …

Aim The diagnosis, severity and extent of a sterile inflammation or a septic infection could be
challenging since there is not one single test able to achieve an accurate diagnosis. The …

The development of extracorporeal life support technology has added a new dimension to
the care of critically ill patients who fail conventional treatment options. Extracorporeal …